한글목차

크론병 치료 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 131억 달러에서 2026년에는 139억 9,000만 달러로, CAGR 6.8%로 성장할 것으로 예상됩니다. 그간의 성장에는 크론병 유병률 증가, 염증성 장질환에 대한 인식 증가, 병원 약국 네트워크의 확대, 기존 항염증제의 가용성, 진단 능력의 향상 등이 요인으로 작용한 것으로 보입니다.

크론병 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 188억 6,000만 달러에 달하고, CAGR은 7.8%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 생물학적 제제 및 저분자 의약품 파이프라인 확대, 맞춤형 치료에 대한 수요 증가, 온라인 약국 보급 확대, 신흥 시장에서의 헬스케어 지출 증가, 장기적인 질병 관리에 대한 관심 증가 등을 꼽았습니다. 예측 기간의 주요 동향으로는 생물학적 요법의 도입 증가, 조기 및 적극적 치료 접근법으로의 전환, 스테로이드 절약 요법에 대한 집중 강화, 경구용 저분자 요법의 성장, 온라인 및 전문 약국 채널의 확대 등이 있습니다.

염증성 장질환의 유병률 증가는 향후 몇 년 동안 크론병 치료 시장의 성장을 견인할 것으로 예상됩니다. 염증성 장질환은 소화관의 염증을 특징으로 하는 만성질환군으로, 구강에서 항문까지 소화기 계통의 모든 부위에 영향을 미칠 수 있습니다. 크론병 치료는 장내 염증을 감소시켜 작용하며, 증상의 재발을 방지하고 질환의 완화를 유지하는데 기여합니다. 예를 들어, 2023년 9월 미국 정부 기관인 국립생물공학정보센터(NCBI)에 따르면, 크론병과 궤양성 대장염의 발병률은 계속 증가하고 있으며, 2023년 염증성 장질환(IBD)의 발병률은 10만 명당 825명으로 예측됩니다. 이 중 크론병 410명, 궤양성 대장염 및 분류불명 IBD 414명입니다. 그 결과, 이러한 질환의 유병률 증가는 크론병 치료 시장의 성장에 기여하고 있습니다.

크론병 치료 시장을 선도하는 주요 기업들은 바이오시밀러인 우스테키누맙과 같은 혁신적인 의약품 개발 및 규제 당국의 승인 획득에 주력하고 있으며, 보다 효과적이고 합리적인 가격의 치료 옵션을 제공함으로써 환자의 치료 성과와 삶의 질을 향상시키고자 노력하고 있습니다. 바이오시밀러 우스테키누맙은 자가면역질환 치료에 사용되는 단클론항체인 레퍼런스 의약품 우스테키누맙과 매우 유사한 생물학적 제제입니다. 예를 들어, 2024년 7월 산도스 인터내셔널(Sandoz International GmbH)은 유럽 전역에서 Pyzchiva(우스테키누맙)를 출시했으며, 이는 크론병에 특화된 130mg 바이알을 포함한 모든 용량의 우스테키누맙 바이오시밀러 중 첫 번째 우스테키누맙 바이오시밀러로 출시되었습니다. 건선, 건선성 관절염, 크론병을 앓고 있는 성인과 6세 이상의 소아에게 사용하도록 승인된 이 제품은 샌즈의 면역학 분야 제품 포트폴리오를 강화하는 동시에 만성 염증성 질환에 대한 비용 효율적인 치료 접근성을 향상시키는 데 기여할 것으로 기대됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Crohn's disease treatment refers to the medical interventions and therapies used to manage Crohn's disease, a chronic inflammatory condition affecting the gastrointestinal tract. The goals of treatment are to reduce intestinal inflammation, prevent symptom flare-ups, and maintain remission.

The main drug types used in Crohn's disease treatment include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others. Antibiotics are medications used to treat and prevent bacterial infections. These drugs are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used in applications including neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, cancer pain, and others.

Tariffs have influenced the Crohn's disease treatment market by increasing the cost of imported active pharmaceutical ingredients, biologics, and advanced manufacturing inputs, impacting overall drug pricing and supply stability. Immunomodulators, biologics, and specialty drugs are most affected, with Asia-Pacific and Europe experiencing notable pressure due to reliance on cross-border pharmaceutical supply chains. However, tariffs have also encouraged local manufacturing, regional sourcing, and domestic API production, supporting long-term supply resilience and reduced import dependency.

The crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides crohn's disease treatment market statistics, including crohn's disease treatment industry global market size, regional shares, competitors with a crohn's disease treatment market share, detailed crohn's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the crohn's disease treatment industry. This crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crohn's disease treatment market size has grown strongly in recent years. It will grow from $13.1 billion in 2025 to $13.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing crohn's disease prevalence, growing awareness of inflammatory bowel diseases, expansion of hospital pharmacy networks, availability of conventional anti-inflammatory drugs, improved diagnostic capabilities.

The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to pipeline expansion of biologics and small molecules, rising demand for personalized treatment, growth of online pharmacy penetration, increasing healthcare expenditure in emerging markets, long-term disease management focus. Major trends in the forecast period include rising adoption of biologic therapies, shift toward early and aggressive treatment approaches, increasing focus on steroid-sparing regimens, growth of oral small-molecule therapies, expansion of online and specialty pharmacy channels.

The growing prevalence of inflammatory bowel disorders is anticipated to drive the expansion of the Crohn's disease treatment market in the coming years. Inflammatory bowel disorders are a group of chronic conditions characterized by inflammation of the gastrointestinal tract and can affect any part of the digestive system, ranging from the mouth to the anus. Crohn's disease treatments work by reducing intestinal inflammation, helping to prevent symptom flare-ups and maintain disease remission. For example, in September 2023, according to the National Center for Biotechnology Information, a US-based government organization, the prevalence of Crohn's disease and ulcerative colitis has continued to rise, with inflammatory bowel disease projected at 825 cases per 100,000 people in 2023, including 410 cases of Crohn's disease and 414 cases of ulcerative colitis and IBD-unclassified. As a result, the increasing prevalence of these conditions is contributing to the growth of the Crohn's disease treatment market.

Leading companies operating in the Crohn's disease treatment market are focusing on the development and regulatory approval of innovative drugs, such as biosimilar ustekinumab, to deliver more effective and affordable treatment options, thereby improving patient outcomes and quality of life. Biosimilar ustekinumab is a biologic medicine that is highly similar to the reference drug ustekinumab, a monoclonal antibody used in the treatment of autoimmune diseases. For instance, in July 2024, Sandoz International GmbH launched Pyzchiva (ustekinumab) across Europe, making it the first ustekinumab biosimilar available in all dosage strengths, including a 130 mg vial specifically indicated for Crohn's disease. The product is approved for use in adults and children over six years of age with plaque psoriasis, psoriatic arthritis, and Crohn's disease, strengthening Sandoz's immunology portfolio while improving access to cost-effective therapies for chronic inflammatory conditions.

In June 2023, Merck acquired Prometheus Biosciences, Inc. for an undisclosed amount. Through this acquisition, Merck aims to reinforce its autoimmune disease pipeline by incorporating Prometheus' innovative therapies for Crohn's disease, ulcerative colitis, and other gastrointestinal disorders. Prometheus Biosciences, Inc. is a US-based company that develops and manufactures targeted treatments for Crohn's disease and related autoimmune conditions.

Major companies operating in the crohn's disease treatment market are AbbVie Inc., Janssen Pharmaceuticals, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Galapagos NV, Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.

North America was the largest region in the global Crohn's disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Crohn's disease treatment market consists of sales of vedolizumab, methotrexate, and infliximab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Crohn's Disease Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses crohn's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crohn's disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The crohn's disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Neuropathic Pain; Fibromyalgia; Chronic Back Pain; Arthritic Pain; Migraine Post-Operative Pain; Cancer Pain; Other Applications
• Subsegments:
• 1) By Antibiotics: Metronidazole; Ciprofloxacin; Other Antibiotics
• 2) By Amino Salicylates: Mesalamine; Sulfasalazine; Other Amino Salicylates
• 3) By Corticosteroids: Prednisone; Budesonide; Other Corticosteroids
• 4) By Immunomodulators: Azathioprine; Methotrexate; Mercaptopurine
• 5) By Other Drug Types: Biologics; Small Molecules; Other Treatments
• Companies Mentioned: AbbVie Inc.; Janssen Pharmaceuticals; Takeda Pharmaceutical Company Limited; Bristol-Myers Squibb Company; Galapagos NV; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Glenmark Pharmaceuticals; Tillotts Pharma AG; Dr. Falk Pharma GmbH; Shire Pharmaceuticals; Salix Pharmaceuticals; Prometheus Laboratories Inc.; Pfizer Inc.; Novartis AG; Sanofi S.A.; Eli Lilly and Company; Boehringer Ingelheim GmbH; Arena Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Crohn's Disease Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Crohn's Disease Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Crohn's Disease Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Crohn's Disease Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Biologic Therapies
  • 4.2.2 Shift Toward Early And Aggressive Treatment Approaches
  • 4.2.3 Increasing Focus On Steroid-Sparing Regimens
  • 4.2.4 Growth Of Oral Small-Molecule Therapies
  • 4.2.5 Expansion Of Online And Specialty Pharmacy Channels

5. Crohn's Disease Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Gastroenterology Clinics
• 5.3 Ambulatory Care Centers
• 5.4 Home Healthcare Providers
• 5.5 Research And Academic Institutes

6. Crohn's Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Crohn's Disease Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Crohn's Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Crohn's Disease Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Crohn's Disease Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Crohn's Disease Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Crohn's Disease Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Crohn's Disease Treatment Market Segmentation

• 9.1. Global Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
• 9.2. Global Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.3. Global Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-Operative Pain, Cancer Pain, Other Applications
• 9.4. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metronidazole, Ciprofloxacin, Other Antibiotics
• 9.5. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Amino Salicylates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mesalamine, Sulfasalazine, Other Amino Salicylates
• 9.6. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prednisone, Budesonide, Other Corticosteroids
• 9.7. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Azathioprine, Methotrexate, Mercaptopurine
• 9.8. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biologics, Small Molecules, Other Treatments

10. Crohn's Disease Treatment Market Regional And Country Analysis

• 10.1. Global Crohn's Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Crohn's Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Crohn's Disease Treatment Market

• 11.1. Asia-Pacific Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Crohn's Disease Treatment Market

• 12.1. China Crohn's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Crohn's Disease Treatment Market

• 13.1. India Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Crohn's Disease Treatment Market

• 14.1. Japan Crohn's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Crohn's Disease Treatment Market

• 15.1. Australia Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Crohn's Disease Treatment Market

• 16.1. Indonesia Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Crohn's Disease Treatment Market

• 17.1. South Korea Crohn's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Crohn's Disease Treatment Market

• 18.1. Taiwan Crohn's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Crohn's Disease Treatment Market

• 19.1. South East Asia Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Crohn's Disease Treatment Market

• 20.1. Western Europe Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Crohn's Disease Treatment Market

• 21.1. UK Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Crohn's Disease Treatment Market

• 22.1. Germany Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Crohn's Disease Treatment Market

• 23.1. France Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Crohn's Disease Treatment Market

• 24.1. Italy Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Crohn's Disease Treatment Market

• 25.1. Spain Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Crohn's Disease Treatment Market

• 26.1. Eastern Europe Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Crohn's Disease Treatment Market

• 27.1. Russia Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Crohn's Disease Treatment Market

• 28.1. North America Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Crohn's Disease Treatment Market

• 29.1. USA Crohn's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Crohn's Disease Treatment Market

• 30.1. Canada Crohn's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Crohn's Disease Treatment Market

• 31.1. South America Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Crohn's Disease Treatment Market

• 32.1. Brazil Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Crohn's Disease Treatment Market

• 33.1. Middle East Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Crohn's Disease Treatment Market

• 34.1. Africa Crohn's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Crohn's Disease Treatment Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Crohn's Disease Treatment Market Regulatory and Investment Landscape

36. Crohn's Disease Treatment Market Competitive Landscape And Company Profiles

• 36.1. Crohn's Disease Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Crohn's Disease Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Crohn's Disease Treatment Market Company Profiles
  • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Janssen Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Galapagos NV Overview, Products and Services, Strategy and Financial Analysis

37. Crohn's Disease Treatment Market Other Major And Innovative Companies

• Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.

38. Global Crohn's Disease Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Crohn's Disease Treatment Market

40. Crohn's Disease Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Crohn's Disease Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Crohn's Disease Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Crohn's Disease Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer